Hypoxia regulation of the cell cycle in malignant melanoma: Putative role for the cyclin-dependent kinase inhibitor p27Kip1

Journal of Cutaneous Pathology

Volumn 31, Issue 7, 2004, Pages 477-482

  Murphy, Michael ^a,d   Carlson, J Andrew ^b   Keough, Martin P ^a   Claffey, Kevin P ^a   Signoretti, Sabina ^c   Loda, Massimo ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d Dowling South ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PROTEIN P27;

ARTICLE; CELL CYCLE; CELL DEATH; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; PROTEIN ANALYSIS; PROTEIN FUNCTION; STAINING; TUMOR CELL;

ANOXIA; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MELANOMA; NECROSIS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 3242743888     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00205.x     Document Type: Article

References (41)

1. Horsman MR. Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys 1998; 42: 710.
2. Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol 2000; 76: 589.
3. Rofstad EK, Eide K, Skoyum R, Hystad ME, Lyng H. Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids. Int J Radiat Biol 1996; 70: 241.
4. Rofstad EK, Maseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol 1999; 75: 1377.
5. Lartigau E, Randrianarivelo H, Avril MF, et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 1997; 7: 400.
6. Hockel M, Vaupel P. Biological consequences of tumor hypoxia [Review]. Semin Oncol 2001; 28 (2 Suppl. 8): 36.
7. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509.
8. Sanna K, Rofstad EK. Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro. Int J Cancer 1994; 58: 258.
9. Rofstad EK. Radiation biology of malignant melanoma. Acta Radiol Oncol 1986; 25: 1.
10. Green SL, Giaccia AJ. Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J Sci Am 1998; 4: 218.
11. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000; 60: 3689.
12. Kip1 and its alterations in tumor cells: a review. J Cell Physiol 2000; 183: 18.
13. Kip1: regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001; 264: 148.
14. Krtolica A, Krucher NA, Ludlow JW. Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities. Oncogene 1998; 17: 2295.
15. Krtolica A, Krucher NA, Ludlow JW. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br J Cancer 1999; 80: 1875.
16. Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 2001; 276: 7919.
17. Green SL, Freiberg RA, Giaccia AJ. p21 (Cip1) and p27 (Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol 2001; 21: 1196.
18. Horiuchi A, Imai T, Shimizu M, et al. Hypoxia-induced changes in the expression of VEGF, HIF-α and cell cycle-related molecules in ovarian cancer cells. Anticancer Res 2002; 22: 2697.
19. Fuji T, Otsuki T, Moriya T, et al. Effect of hypoxia on human seminoma cells. Int J Oncol 2002; 20: 955.
20. Goda N, Ryan HE, Khadivi B, et al. Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003; 23: 359.
21. Kip1 is upregulated by hypoxia via an ARNT dependent pathway. J Cell Biol 2003; 90: 548.
22. Sutherland RM. Tumor hypoxia and gene expression - implications for malignant progression and therapy. Acta Oncol 1998; 37: 567.
23. Koong AC, Denko NC, Hudson KM, et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000; 60: 883.
24. Rofstad EK, Halsor EF. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. Br J Cancer 2002; 21: 301.
25. Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002; 15: 1847.
26. Kunz M, Moeller S, Koczan D, et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 2003; 278: 45651.
27. Yang RM, Naitoh J, Murphy M, et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 1998; 159: 941.
28. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 1998; 153: 681.
29. Moreira G, Colleoni GWB, Cangi MG, et al. Reciprocal Cdc25A and p27 expression in B-cell non-Hodgkins lymphomas. Mol Diagn Pathol 2003; 12: 128.
30. Czajkowski R, Drewa T, Wozniak A, Krzyzynska-Malinowska E. Cell cycle in sporadic melanoma. Int J Dermatol 2002; 41: 550.
31. 1/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer 2000; 28: 404.
32. Zhang H & Rosdahl I. Expression of oncogenes, tumour suppressor, mismatch repair and apoptosis-related genes in primary and metastatic melanoma cells. Int J Oncol 2001; 19: 1149.
33. Zhang H, Schneider J, Rosdahl I. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Int J Oncol 2002; 21: 43.
34. Kip1 in malignant melanoma. Inverse correlation with disease-free survival. Am J Pathol 1998; 153: 305.
35. Kip1 and cyclin E in invasive primary malignant melanomas. J Invest Dermatol 1999; 113: 1039.
36. Morgan MB, Cowper SE. Expression of p27 (kip1) in nevi and melanomas. Am J Dermatopathol 1999; 21: 121.
37. Murphy M, Signoretti S, Carlson JA, Loda M. p27 expression in malignant melanoma [Abstract]. J Cutan Pathol 2000; 27: 324.
38. Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA, Slingerland JM. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res 1999; 59: 684.
39. Murphy M, Carlson JA. Can we reliably use markers of cell cycle regulation (e.g. Ki-67, p21, p27, p53) to differentiate between benign and malignant skin tumors? J Cutan Pathol 2001; 28: 219.
40. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 1998; 4: 575.
41. Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect 2002; 110 (Suppl. 5): 783.